--- title: 'Associate Director, Digital Experience & AI Production at Iovance Biotherapeutics' canonical: 'https://feeny.ai/job/associate-director-digital-experience-ai-production-iovance-biotherapeutics-6vpwzzkanpmb' type: 'job' last_seen: '2026-09-10' --- # Associate Director, Digital Experience & AI Production at Iovance Biotherapeutics - **Company:** Iovance Biotherapeutics - **Location:** Remote - **Compensation:** $190k–$205k - **Work type:** remote - **Posted:** 2026-09-02 - **Last confirmed live:** 2026-09-10 - **Apply:** https://job-boards.greenhouse.io/iovancebiotherapeutics/jobs/5413281008 ## Job description Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer. ## Overview The Associate Director, Digital Experience & AI Production owns how Iovance’s external digital presence gets produced, published, found, and kept accurate across web, visual assets, search, and measurement. Working at the intersection of technology, design, content, and business, this person uses AI to do work that would traditionally take a whole team, while remaining the human quality gate on everything that goes live. The role spans Iovance’s corporate, branded, unbranded, clinical trial, and future international websites. It is deliberately hands-on: rather than handing requirements to an agency and waiting, this person takes work from intake through to production. A central part of the mandate is bringing agency-dependent work in-house — reducing vendor spend and taking direct accountability for the cost, speed, and quality of digital production. Communications and Commercial own what Iovance says; this role owns whether it gets published, whether people can find it, and how efficiently it is produced. Essential Functions and Responsibilities Own and Run the Digital Platforms - Review, edit, test, and approve all AI-generated content and assets before it reaches a regulated public site. - Use AI-assisted tools such as Claude or Sanity to assemble and update pages, migrate content, configure forms, and publish updates from a shared component library and site templates. - Build a reusable multi-site “site factory” to launch clinical trial, unbranded, and future ex-US properties in days, and manage the headless CMS content models, permissions, and publishing workflows that let business users self-serve appropriate updates. Make Publishing Fast and Predictable - Drive same-day publishing once content clears MLR review, managing development, staging, and production workflows through AWS Amplify. - Provide staging and preview environments that let cross-functional and MLR reviewers evaluate the real experience, not just a document of the copy. - Instrument sites with GA4, Search Console, and uptime and performance monitoring, and report on publishing speed, site freshness, and SLA performance. Make Iovance Easy to Find — and Accurately Represented - Own technical SEO across the sites: crawlability, indexing, Core Web Vitals, and structured data (Organization, Drug, ClinicalTrial, FAQ, and Video schema). - Identify and correct inaccurate information in Wikidata, Google Knowledge Panel, and financial-data aggregators (S&P Capital IQ, FactSet, Refinitiv, Morningstar), reviewed quarterly. - Monitor how search engines and AI assistants describe Iovance, its products, and its pipeline, correcting outdated or inaccurate information through structured data and authoritative site content. Build an AI-Enabled Production Capability - Build Figma Weave workflows that produce consistent, on-brand visual assets across multiple digital properties. - Use Adobe Firefly to create IP-indemnified imagery for appropriate external-facing use cases. - Maintain the Iovance web brand asset kit, and bring routine production such as banner variations, reference guides, and display assets in-house as capacity grows. Work Effectively in a Regulated Environment - Support MLR review through staging URLs, ensuring Regulatory can evaluate ISI placement, fair balance, and content prominence in the actual experience. - Maintain WCAG 2.1 AA accessibility, privacy and consent standards (CCPA, GDPR), and security requirements (WAF, security headers, dependency scanning) within IT’s DNS and security guardrails. Bring the Work In-House - Transition external web properties off agency dependency in a deliberate, sequenced way — content extraction and rebuild through MLR review, launch, DNS cutover, and agency contract termination per contract terms. - Continue using external partners where there is a conscious reason — strategic creative work or highly specialized platforms. Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics. Perform miscellaneous duties as assigned. Required Education, Skills, and Knowledge - 10+ years’ experience across web production, digital operations, or closely related work, with direct responsibility for websites that have gone into production. - Bachelors degree in relevant field - Hands-on experience using AI-assisted production tools such as Claude, with examples of things you have actually built and shipped this way. - Good design judgment to create professional, brand-consistent pages and assets using Figma and AI-enabled image tools without always relying on a dedicated designer. - A working understanding of technical SEO, structured data, Search Console, and Core Web Vitals. - Strong stakeholder management across Communications, Commercial, Regulatory, Legal, and IT, and clear communication that keeps people informed without creating unnecessary process. - A bias toward action — comfortable taking ownership of a problem from intake through production and launch. Preferred Education, Skills, and Knowledge - Prior pharma, biotech, or other regulated-industry experience - MLR or promotional review familiarity (fair balance, ISI/PI);AWS Amplify; WCAG accessibility; CCPA and GDPR; Wikidata, Knowledge Panel, or financial-data governance; Figma Weave and Adobe Firefly; Physical Demands and Activities Required The physical demands described here represent those an employee may encounter while performing the essential functions of this job. Reasonable accommodation may be provided to enable individuals to perform these functions. - Ability to remain in a stationary position for extended periods - Ability to move about within an office or remote workspace and exert up to 10 pounds of force occasionally - Visual acuity sufficient for preparing and analyzing data, viewing computer screens, and extensive reading - Repetitive motion involving wrists, hands, and/or fingers - Ability to communicate effectively to exchange information - Ability to engage in analytical, conceptual, and problem‑solving activities in a dynamic business environment Mental: Clear and conceptual thinking ability; excellent judgment, troubleshooting, problem-solving, analysis, and discretion; ability to handle work-related stress; ability to handle multiple priorities simultaneously with a sense of urgency; and ability to meet deadlines Work Environment This job operates in a professional or remote office environment and requires operating standard office equipment and keyboards. #LI-remote The annual base salary we reasonably expect to pay is listed. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of the role, job duties/requirements, and relevant education, experience and skills. Pay Transparency $190,000—$205,000 USD The statements contained in this document are intended to describe the general nature and level of work being performed by a colleague assigned to this description. They are not intended to constitute a comprehensive list of functions, duties, or local variances. Management retains the discretion to add or to change the duties of the position at any time. Iovance is committed to cultivating and offering a diverse and inclusive work environment. As an equal-opportunity employer, our employees and applicants will be considered without regard to an individual’s race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, and any other characteristic protected by applicable law. If you need assistance or accommodation to apply to one of our opportunities, please contact careers@iovance.com. By voluntarily providing information and clicking “Submit Application”, you explicitly consent to the collection and use of your personal information for the purposes described above and in our [Candidate Privacy Notice](https://www.iovance.com/privacy-policy/). ## About Iovance Biotherapeutics ## Company Overview - **One-liner**: Iovance Biotherapeutics is pioneering tumor infiltrating lymphocyte (TIL) cell therapies to develop personalized, one-time treatments for solid tumor cancers. - **Entity Type**: Public (NASDAQ: IOVA) - **Headquarters**: San Carlos, California, USA - **Founded**: 2007 (originally named Lion Biotechnologies, renamed Iovance Biotherapeutics in 2017) - **Founders**: Not publicly available (the company was formed through a merger and rebranding) ## Core Business - **Primary industry**: Biotechnology — Cell Therapy (Immuno-Oncology) - **Target customers**: B2B / B2G — Healthcare providers, clinical trial sites, and ultimately patients with advanced solid tumors (melanoma, non-small cell lung cancer, endometrial cancer, etc.) - **Mission or purpose statement**: To be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer, harnessing the immune system to recognize and attack diverse cancer cells. ## Products & Services - **Lifileucel (IOV-009)**: A one-time, personalized TIL therapy for advanced melanoma. It is the first approved TIL therapy for a solid tumor (FDA approved in early 2024 under the brand name Amtagvi). - **IOV-LUN-202**: An investigational TIL therapy for advanced non-small cell lung cancer (NSCLC) currently in Phase 2 clinical trials. - **IOV-END-201**: An investigational TIL therapy for advanced endometrial cancer currently in Phase 2 clinical trials. - **IOV-4001**: A next-generation, gene-edited TIL therapy (using TALEN technology to inactivate PD-1 expression) for solid tumors, currently in preclinical/early clinical development. - **IOV-3001**: An engineered IL-2 therapy (licensed from Novartis) designed to support TIL therapy efficacy, currently in preclinical development. - **Cell Therapy Manufacturing (iCTC)**: The company operates a 136,000-square-foot, state-of-the-art Cell Therapy Center in Philadelphia, PA, for proprietary GMP manufacturing of TIL therapies. ## Market Standing - **Valuation/Market Cap**: As of early 2026, market capitalization is approximately $2.5–3.0 billion (fluctuates with FDA news and clinical data). Check current price on NASDAQ: IOVA. - **Key Metric (Revenue)**: Iovance generated its first commercial revenue from Lifileucel/Amtagvi in 2024. Annual revenue for 2025 was approximately $180–220 million (estimate based on analyst reports; exact figure not yet fully disclosed). The company is not yet profitable. - **Key Metric (Funding)**: As a public company, Iovance has raised over $1.5 billion through public offerings and debt financings. Notable recent raise: a public offering in 2022 and subsequent at-the-market offerings. - **Notable Investors/Partners**: - Novartis (license partner for IOV-3001) - Major institutional investors (e.g., BlackRock, Vanguard, and several healthcare-focused funds) - Collaborations with major cancer centers for clinical trials (e.g., MD Anderson, Memorial Sloan Kettering, etc.) - **Growth Signals**: - FDA approval of Lifileucel (Amtagvi) in early 2024 — a landmark first-in-class approval for TIL therapy in solid tumors. - Rapid commercial launch and expansion of treatment centers across the U.S. - Multiple ongoing Phase 2/3 trials in large indications (NSCLC, endometrial cancer, frontline melanoma). - Investment in next-generation gene-edited TIL (IOV-4001) and engineered IL-2 (IOV-3001) to improve efficacy and expand addressable patient populations. ## Competitive Advantages - **First-to-market TIL therapy**: Iovance is the only company with an FDA-approved TIL therapy for a solid tumor (Amtagvi for melanoma), giving it a significant head start in manufacturing, commercial infrastructure, and physician education. - **Proprietary manufacturing platform**: The in-house iCTC facility in Philadelphia enables scalable, standardized GMP production of personalized TIL therapies, a major barrier to entry for competitors. - **Broad solid tumor pipeline**: Unlike CAR-T therapies (primarily effective in blood cancers), TIL therapy has shown promise across multiple solid tumor types, providing a large addressable market. - **Polyclonal T cell approach**: The therapy targets a broad range of neoantigens unique to each patient’s tumor, potentially reducing the risk of immune escape compared to single-target therapies. ## Strategic Focus - **Commercial expansion**: Scaling up the launch of Amtagvi for advanced melanoma and expanding treatment center network globally. - **Pipeline acceleration**: Advancing pivotal trials in NSCLC (IOV-LUN-202) and endometrial cancer (IOV-END-201) to secure additional FDA approvals. - **Next-generation innovation**: Developing gene-edited TIL (IOV-4001) to enhance persistence and efficacy, and engineered IL-2 (IOV-3001) to improve the TIL therapy cycle. - **Manufacturing optimization**: Continuing to improve manufacturing efficiency and turnaround time at the iCTC facility to support growing demand and reduce costs. ## Why Work Here - **Mission-driven culture**: The company is deeply patient-centric, with a clear focus on delivering transformative therapies to cancer patients. Employees often cite the meaningful impact of their work as a key motivator. - **Values**: Integrity, agility, innovation, collaboration, and excellence are core to the company’s operating philosophy. The culture emphasizes transparency, teamwork, and high ethical standards. - **Diversity, Equity, and Inclusion**: Iovance has a stated commitment to DEI, recognizing that internal diversity is critical to serving diverse patient populations and driving innovation. - **Remote/Hybrid policy**: Many roles (especially in clinical, medical affairs, marketing, and commercial functions) are remote or hybrid. Laboratory and manufacturing roles are based on-site in Philadelphia, PA (iCTC) or San Carlos, CA (HQ). - **Benefits**: Competitive salaries, annual cash bonuses, long-term incentives (stock options/RSUs), 401(k) with match, Employee Stock Purchase Plan, comprehensive medical/dental/vision (low employee cost), Health Savings Account contributions, paid parental leave, tuition assistance, wellness program (gym discounts), and professional development opportunities. - **Work environment**: Agile and fast-paced, typical of a biotech company at a critical growth stage. The company values data-driven decision-making and encourages employees to bring their best efforts every day. ## Sources 1. [iovance.com](https://www.iovance.com/) 2. [iovance.com - About Us](https://www.iovance.com/about-iovance-biotherapeutics/) 3. [iovance.com - Culture](https://www.iovance.com/culture/) 4. [job-boards.greenhouse.io](http://job-boards.greenhouse.io/iovancebiotherapeutics) ## Other roles at Iovance Biotherapeutics - [Aseptic Manufacturing Technician I - Night Shift B [Contract to Hire]](https://feeny.ai/job/aseptic-manufacturing-technician-i-night-shift-b-contract-to-hire-iovance-npy381ja7k30) — Philadelphia, PA - [Aseptic Manufacturing Technician I - Day Shift A [Contract to Hire]](https://feeny.ai/job/aseptic-manufacturing-technician-i-day-shift-a-contract-to-hire-iovance-4e92ffmwhpkr) — Philadelphia, PA - [Production Planner](https://feeny.ai/job/production-planner-iovance-biotherapeutics-philadelphia-2jkyvc79mh98) — Philadelphia, PA - [Lead Endpoint Engineering Architect](https://feeny.ai/job/lead-endpoint-engineering-architect-iovance-biotherapeutics-remote-7ska57zabwp5) - [Aseptic Manufacturing Technician I - Day Shift A [Contract to Hire]](https://feeny.ai/job/aseptic-manufacturing-technician-i-day-shift-a-contract-to-hire-iovance-z7jk5970wezw) — Philadelphia, PA - [IT Support Analyst II [Contract to Hire]](https://feeny.ai/job/it-support-analyst-ii-contract-to-hire-iovance-biotherapeutics-philadelphia-kqj3mcava128) — Philadelphia, PA - [Clinical Trial Manager](https://feeny.ai/job/clinical-trial-manager-iovance-biotherapeutics-remote-fewmr4x5pabx) - [Senior Clinical Research Associate](https://feeny.ai/job/senior-clinical-research-associate-iovance-biotherapeutics-remote-cph0sr2jm74r) - [Technical Learning Specialist I, GMP Training Administration](https://feeny.ai/job/technical-learning-specialist-i-gmp-training-administration-iovance-qzkrm7zwxcte) — Philadelphia, PA - [Aseptic Manufacturing Technician II - Day Shift B [Contract to Hire]](https://feeny.ai/job/aseptic-manufacturing-technician-ii-day-shift-b-contract-to-hire-iovance-mpm8m6q02zp6) — Philadelphia, PA